Literature DB >> 21762564

A randomized trial of conventional chest physical therapy versus high frequency chest wall compressions in intubated and non-intubated adults.

Darnetta Clinkscale1, Kathleen Spihlman, Peggy Watts, Daniel Rosenbluth, Marin H Kollef.   

Abstract

BACKGROUND: Conventional chest physical therapy (CCPT), applied by therapists using cupped hands to perform percussion, is commonly used in hospitalized adults. However, increased work load demands and occupational health concerns (eg, carpal tunnel syndrome) limit the overall utilization of this therapy. Therefore, we conducted a study to compare the overall effectiveness of CCPT to high-frequency chest wall compressions (HFCWC) applied via a vibratory vest.
METHODS: A single-center, randomized trial among hospitalized intubated and non-intubated adult patients requiring chest physical therapy comparing CCPT and HFCWC. The primary outcome measure was hospital stay.
RESULTS: A total of 280 per-protocol patients (out of an a priori estimated 320 patients required to demonstrate a 20% relative reduction in hospital stay) were randomly assigned to receive CCPT (no. = 146, 52.1%) or HFCWC (no. = 134, 47.9%). The hospital stay was 12.5 ± 8.8 days for patients randomized to CCPT and 13.0 ± 8.9 days for patients randomized to HFCWC (P = .62). Patient comfort was assessed using a visual analog scale (increasing score reflects greater discomfort) and was statistically greater for patients randomized to CCPT compared to HFCWC (2.2 ± 0.8 vs 1.9 ± 0.8, P = .009). The duration of time until radiographic resolution of lobar atelectasis trended less for CCPT compared to HFCWC (5.2 ± 4.3 d vs 6.5 ± 5.2 d, P = .051). All other secondary outcomes, including hospital mortality and nosocomial pneumonia, were similar for both treatment groups.
CONCLUSIONS: This study was inadequately powered for the primary outcome of interest and hence we cannot make recommendations on the preferential use of HFCWC or CCPT for intubated and non-intubated adult patients. HFCWC was associated with statistically better comfort scores. (ClinicalTrials.gov registration NCT00717873.).

Entities:  

Mesh:

Year:  2011        PMID: 21762564     DOI: 10.4187/respcare.01299

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  7 in total

1.  Oscillating devices for airway clearance in people with cystic fibrosis.

Authors:  Lisa Morrison; Stephanie Milroy
Journal:  Cochrane Database Syst Rev       Date:  2020-04-30

Review 2.  Airway clearance techniques for bronchiectasis.

Authors:  Annemarie L Lee; Angela T Burge; Anne E Holland
Journal:  Cochrane Database Syst Rev       Date:  2015-11-23

3.  Instantaneous responses to high-frequency chest wall oscillation in patients with acute pneumonic respiratory failure receiving mechanical ventilation: A randomized controlled study.

Authors:  Ming-Lung Chuang; Yi-Ling Chou; Chai-Yuan Lee; Shih-Feng Huang
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

Review 4.  Expiratory rib cage compression in mechanically ventilated adults: systematic review with meta-analysis.

Authors:  Lúcia Faria Borges; Mateus Sasso Saraiva; Marcos Ariel Sasso Saraiva; Fabrício Edler Macagnan; Adriana Kessler
Journal:  Rev Bras Ter Intensiva       Date:  2017 Jan-Mar

5.  Active cycle of breathing technique may reduce pulmonary complications after esophagectomy: A randomized clinical trial.

Authors:  Jiudi Zhong; Siwen Zhang; Chuangzhen Li; Yi Hu; Weijin Wei; Li Liu; Ming Wang; Zhangxian Hong; Hao Long; Tiehua Rong; Hong Yang; Xiaodong Su
Journal:  Thorac Cancer       Date:  2021-11-12       Impact factor: 3.500

Review 6.  Mucus Clearance Strategies in Mechanically Ventilated Patients.

Authors:  Ryan L Goetz; Kadambari Vijaykumar; George M Solomon
Journal:  Front Physiol       Date:  2022-03-23       Impact factor: 4.566

7.  What Is the Best Pulmonary Physiotherapy Method in ICU?

Authors:  Ufuk Kuyrukluyildiz; Orhan Binici; İlke Kupeli; Nurel Erturk; Barış Gulhan; Fethi Akyol; Adalet Ozcicek; Didem Onk; Guldane Karabakan
Journal:  Can Respir J       Date:  2016-04-24       Impact factor: 2.409

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.